News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
680,843 Results
Type
Article (46138)
Company Profile (184)
Press Release (634506)
Multimedia
Podcasts (118)
Webinars (20)
Section
Business (188936)
Career Advice (2607)
Deals (33721)
Drug Delivery (139)
Drug Development (80205)
Employer Resources (151)
FDA (15595)
Job Trends (14295)
News (326657)
Policy (31961)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2674)
Academic (1)
Accelerated approval (43)
Adcomms (32)
Allergies (161)
Alliances (46707)
ALS (201)
Alzheimer's disease (1790)
Antibody-drug conjugate (ADC) (431)
Approvals (15901)
Artificial intelligence (630)
Autoimmune disease (234)
Automation (48)
Bankruptcy (339)
Best Places to Work (10954)
BIOSECURE Act (18)
Biosimilars (209)
Biotechnology (98)
Bladder cancer (180)
Brain cancer (68)
Breast cancer (688)
Cancer (5484)
Cardiovascular disease (468)
Career advice (2231)
Career pathing (45)
CAR-T (299)
CDC (54)
Cell therapy (811)
Cervical cancer (39)
Clinical research (69394)
Collaboration (1906)
Company closure (5)
Compensation (1009)
Complete response letters (91)
COVID-19 (2700)
CRISPR (100)
C-suite (1101)
Cystic fibrosis (140)
Data (7272)
Decentralized trials (3)
Denatured (28)
Depression (167)
Dermatology (68)
Diabetes (551)
Diagnostics (6659)
Digital health (46)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (292)
Drug pricing (203)
Drug shortages (33)
Duchenne muscular dystrophy (270)
Earnings (78438)
Editorial (64)
Employer branding (21)
Employer resources (141)
Events (106073)
Executive appointments (1111)
FDA (18985)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1530)
Gene editing (210)
Generative AI (59)
Gene therapy (694)
GLP-1 (1066)
Government (4654)
Grass and pollen (7)
Guidances (403)
Healthcare (17533)
HIV (77)
Huntington's disease (53)
IgA nephropathy (94)
Immunology and inflammation (301)
Immuno-oncology (87)
Indications (158)
Infectious disease (3022)
Inflammatory bowel disease (207)
Inflation Reduction Act (14)
Influenza (127)
Intellectual property (267)
Interviews (539)
IPO (15169)
IRA (53)
Job creations (3668)
Job search strategy (1806)
JPM (65)
Kidney cancer (20)
Labor market (74)
Layoffs (566)
Leadership (46)
Legal (7661)
Liver cancer (99)
Longevity (24)
Lung cancer (754)
Lymphoma (406)
Machine learning (49)
Management (54)
Manufacturing (943)
MASH (196)
Medical device (11989)
Medtech (12066)
Mergers & acquisitions (19699)
Metabolic disorders (1463)
mRNA (186)
Multiple sclerosis (182)
NASH (24)
Neurodegenerative disease (398)
Neuropsychiatric disorders (111)
Neuroscience (3262)
Neurotech (1)
NextGen: Class of 2026 (6093)
Non-profit (4248)
Now hiring (66)
Obesity (685)
Opinion (322)
Ovarian cancer (203)
Pain (249)
Pancreatic cancer (274)
Parkinson's disease (345)
Partnered (33)
Patents (553)
Patient recruitment (611)
Peanut (55)
People (59982)
Pharmaceutical (68)
Pharmacy benefit managers (24)
Phase 1 (21247)
Phase 2 (30498)
Phase 3 (23199)
Pipeline (7514)
Policy (319)
Postmarket research (2606)
Preclinical (8895)
Press Release (72)
Prostate cancer (280)
Psychedelics (59)
Radiopharmaceuticals (299)
Rare diseases (1045)
Real estate (5522)
Recruiting (64)
Regulatory (24668)
Reports (33)
Research institute (2351)
Resumes & cover letters (378)
Rett syndrome (33)
RNA editing (21)
RSV (79)
Schizophrenia (180)
Series A (257)
Series B (184)
Service/supplier (5)
Sickle cell disease (112)
Special edition (22)
Spinal muscular atrophy (169)
Sponsored (44)
Startups (3348)
State (2)
Stomach cancer (19)
Supply chain (120)
Tariffs (92)
The Weekly (87)
Vaccines (1037)
Venture capital (99)
Weight loss (455)
Women's health (97)
Worklife (22)
Date
Last 7 days (738)
Last 30 days (2453)
Last 365 days (28835)
2026 (9383)
2025 (28919)
2024 (33501)
2023 (37787)
2022 (48769)
2021 (52756)
2020 (51305)
2019 (44117)
2018 (33606)
2017 (31254)
2016 (30469)
2015 (35768)
2014 (29030)
2013 (24325)
2012 (25767)
2011 (26781)
2010 (24669)
Location
Africa (859)
Alabama (87)
Alaska (6)
Arizona (279)
Arkansas (15)
Asia (41516)
Australia (7643)
California (11436)
Canada (3518)
China (1268)
Colorado (516)
Connecticut (483)
Delaware (360)
Europe (91398)
Florida (1788)
Georgia (361)
Hawaii (2)
Idaho (60)
Illinois (977)
India (87)
Indiana (519)
Iowa (19)
Japan (511)
Kansas (120)
Kentucky (42)
Louisiana (38)
Maine (80)
Maryland (1425)
Massachusetts (8312)
Michigan (344)
Minnesota (604)
Mississippi (5)
Missouri (143)
Montana (31)
Nebraska (26)
Nevada (125)
New Hampshire (81)
New Jersey (3280)
New Mexico (23)
New York (3108)
North Carolina (1529)
North Dakota (8)
Northern California (5664)
Ohio (338)
Oklahoma (18)
Oregon (40)
Pennsylvania (2332)
Puerto Rico (28)
Rhode Island (42)
South America (1166)
South Carolina (80)
South Dakota (2)
Southern California (4553)
Tennessee (187)
Texas (1881)
United States (41418)
Utah (361)
Vermont (1)
Virginia (309)
Washington D.C. (69)
Washington State (941)
West Virginia (4)
Wisconsin (112)
Wyoming (2)
680,843 Results for "kadmon corporation formerly known as kadmon pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Sanofi Closes NY Kadmon Facility in Effort to Simplify Operations
Six months after acquiring Kadmon Holdings, pharma giant Sanofi is closing Kadmon’s New York facility. As part of the paring down, Sanofi is also laying off 25 employees at the location.
April 7, 2022
·
2 min read
·
Hannah Chudleigh
Press Releases
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 30, 2026
·
19 min read
Deals
Sanofi completes acquisition of Kadmon
Paris– November9, 2021 - Sanofi announced the completion of its acquisition of Kadmon Holdings, Inc.
November 9, 2021
·
5 min read
Press Releases
BreezeBio (Formerly GenEdit) Announces Series B Financing to Advance Internal Pipeline of Precision Genetic Medicines
February 25, 2026
·
4 min read
Business
Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results
Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the third quarter of 2021.
November 4, 2021
·
14 min read
Press Releases
Kiniksa Pharmaceuticals Provides Corporate Update
January 12, 2026
·
11 min read
Press Releases
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
March 25, 2026
·
2 min read
Deals
Sanofi to acquire Kadmon to further strengthen growth of transplant business
Sanofi has entered into a definitive merger agreement with Kadmon Holdings, Inc. a biopharmaceutical company that discovers, develops, and markets transformative therapies for disease areas of significant unmet medical needs.
September 8, 2021
·
11 min read
Press Releases
Verrica Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide a Corporate Update on March 11, 2026
March 5, 2026
·
1 min read
Business
Kadmon Provides Business Update and Reports Second Quarter 2021 Financial Results
Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the second quarter of 2021.
August 5, 2021
·
10 min read
1 of 68,085
Next
